Bafna Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Navin Kumar as an Additional Director (Non- Executive Independent Director) of the company w.e.f. Jun 23, 2025
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has appointed Mr. Navin Kumar (DIN: 08778662) as an Additional Director in the Non-Executive Independent Director category, effective June 23, 2025. The appointment is for a one-year term and is subject to shareholder approval at the next general meeting. Mr. Navin Kumar is a Chartered Accountant with over 13 years of experience in corporate finance, taxation, auditing, GST, and regulatory compliance. The company confirmed that he is not debarred from holding the directorship by any SEBI order or other authority. No relationships with existing directors were disclosed.
This is a routine board-level appointment aimed at strengthening governance and adding financial expertise to the board. It is unlikely to have any immediate material impact on the stock price, though shareholder approval will be sought in due course.